Dimeric Inhibin A as a Marker for Down's Syndrome in Early Pregnancy

Aitken, David A.; Wallace, Euan M.; Crossley, Jennifer A.; Swanston, Ian A.; van Pareren, Yvonne; van Maarle, Merel; Groome, Nigel P.; Macri, James N.; Connor, J. Michael
May 1996
New England Journal of Medicine;5/09/96, Vol. 334 Issue 19, p1231
Academic Journal
Background: In screening for Down's syndrome in the second trimester of pregnancy, the concentrations of alpha-fetoprotein, the β subunit of human chorionic gonadotropin, and intact human chorionic gonadotropin in maternal serum are widely used markers. We investigated a new marker, dimeric inhibin A, and compared its predictive value with that of the established markers. Methods: Serum samples were obtained at 7 to 18 weeks of gestation from 58 women whose fetuses were known to be affected by Down's syndrome, 32 whose fetuses were affected by trisomy 18, and 438 whose fetuses were normal, and the samples were analyzed for each marker. Individual serum concentrations of each marker were converted to multiples of the median value at the appropriate length of gestation in the women with normal pregnancies, and rates of detection of Down's syndrome by screening for inhibin A in various combinations with the other markers were estimated by multivariate analysis. Results: In the women with fetuses affected by Down's syndrome, the serum inhibin A concentrations were 2.06 times the median value in the women with normal pregnancies (P<0.001). This compared with 2.00 times the median for the β subunit of human chorionic gonadotropin, 1.82 times the median for intact human chorionic gonadotropin, and 0.72 times the median for alpha-fetoprotein. The serum concentrations of inhibin A in the women with fetuses affected by Down's syndrome did not appear to be significantly elevated above normal until the end of the first trimester and were not significantly different from normal in the women with fetuses affected by trisomy 18 (P = 0.17). The rate of detection of Down's syndrome was 53 percent and the false positive rate was 5 percent when alpha-fetoprotein, the β subunit of human chorionic gonadotropin, and maternal age were used together as predictors. The detection rate increased to 75 percent when inhibin A was added (P = 0.002). Conclusions: In the second trimester of pregnancy, measuring inhibin A in maternal serum, in combination with measurements of alpha-fetoprotein and the β subunit of human chorionic gonadotropin, significantly improved the rate of detection of Down's syndrome. (N Engl J Med 1996;334:1231-6.)


Related Articles

  • Stability of inhibin A and unconjugated oestriol in the second trimester of pregnancy. Brown, Louise F.; Shearing, Catherine H.; Tydeman, Graham // Annals of Clinical Biochemistry;Jan2011, Vol. 48 Issue 1, p72 

    Background: The introduction of a second trimester quadruple test for fetal Down's syndrome adds the measurement of serum inhibin A (InhA) and unconjugated oestriol (UE3) to the existing repertoire of alphafetoprotein and intact human chorionic gonadotrophin. The aim of this study was to assess...

  • Evaluation of a Dimeric Inhibin-A Assay for Assessing Fetal Down Syndrome. Erickson, J. Alan; Ashwood, Edward R.; Gin, Cynthia A. // Archives of Pathology & Laboratory Medicine;Apr2004, Vol. 128 Issue 4, p415 

    Context.—Several studies report the role of dimeric inhibin-A in assessing risk for fetal Down syndrome. The majority, however, use the Serotec inhibin-A assay and not the newer Diagnostic Systems Laboratories inhibin-A enzyme-linked immunosorbent assay (ELISA). Objectives.—To...

  • Atlantoaxial instability in Down syndrome. Walling, Anne D. // American Family Physician;12/1/1993, Vol. 48 Issue 8, p1541 

    Reports on a study that assessed the presumed risk of spinal cord compression during sports participation in children with Down syndrome, as presented in the periodical `The Lancet' dated August 28, 1993. Prevalences of atlantoaxial instability in children with Down syndrome; Rare occurrence of...

  • `My amazing Lisa.' Grassman, A.S. // Redbook;Apr89, Vol. 172 Issue 6, p56 

    A mother describes her attempts to love and care for her daughter, who has Down syndrome.

  • A better mother for my son. Kline, Karen; Hope, Jack // Redbook;Jul92, Vol. 179 Issue 3, p157 

    Recounts the author's feelings after giving birth to a Down Syndrome child. Tells how she and her husband examined their options and finally decided to put the baby up for adoption.

  • Quadruple test is available for Down's syndrome. Wise, Jacqui // BMJ: British Medical Journal (International Edition);8/17/96, Vol. 313 Issue 7054, p380 

    Reports on a novel test for Down's syndrome, a genetic disorder caused by a chromosomal aberration in the afflicted individual. Antenatal screening tests for Down's syndrome; Reliability of the test; Comparison with biochemical markers as a test.

  • To confound the wise and the strong. Samway, P.H. // America;11/21/1987, Vol. 157 Issue 15, p372 

    Efforts being made across the country to help people with Down's syndrome. Describes former ways of dealing with Down's syndrome children and their parents. Since the late 1960's and early 1970's, parents with children who have Down's syndrome have learned they must educate both themselves and...

  • Quick test spots medical disorders in unborn.  // Current Science;10/5/90, Vol. 75 Issue 3, p13 

    Reports that a new test has been developed that quickly tells if an unborn child has a medical disorder known as Down's syndrome. Details.

  • Things Danny taught me. Maier, Francis X. // Commonweal;3/26/93, Vol. 120 Issue 6, p11 

    Presents the author's comments on what he has learned from his Down's syndrome son. His reaction when his wife unexpectedly became pregnant at age 41; How he discovered his son had Down's syndrome; What he discovered about himself in the days after his son's birth; His feelings that his family...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics